#BiotechIndustry 🧬

[marketingreportz]

Bioprocess containers Market Industry Forecast, 2024–2030

Bioprocess Containers Market Overview

Request Sample :

A major trend is the growing demand for single-use bioprocess containers. Single-use bioprocess containers eliminate cleaning requirements between batches and reduce the risk of batch failure due to cross-contamination. Additionally, single-use systems are also cost effective. Respondents identified lower-cost single use devices as the most important area of interest for new products and technologies in 2023. Another notable trend is the rise in upstream bioprocess products driven by increasing demand for biopharmaceuticals, including biologics and gene therapies. As the industry focuses on enhancing cell culture, fermentation, and early-stage production efficiencies, there is a heightened need for advanced upstream bioprocess products to support these developments. According to a February 2024 article in BioProcess International, the top areas in upstream production were cell-culture media, bioreactors, and information technology (IT), which encompasses automation, software, and networking. Interest in IT solutions among respondents grew from 21.1% in 2022 to 29% in 2023.

COVID-19 / Ukraine Crisis — Impact Analysis:

The COVID-19 pandemic significantly accelerated the growth of the bioprocess containers market, driven by the urgent demand for vaccine production and biologics manufacturing. As pharmaceutical companies ramped up production, flexible and scalable solutions like single-use bioprocess containers became critical for handling cell cultures, reagents, and drug formulations. Additionally, disruptions in global supply chains and a heightened focus on healthcare infrastructure underscored the importance of efficient bioprocessing technologies. Post-pandemic, the market continues to grow, with increased interest in biologics, gene therapies, and personalized medicine fueling demand for flexible manufacturing solutions.

The Ukraine-Russia war has disrupted global supply chains, impacting the bioprocess containers market. The conflict has led to shortages of raw materials, increased transportation costs, and delays in production for biopharma manufacturing. Europe, a key region for bioprocessing, has been particularly affected by rising energy prices and supply chain instability. Companies have been forced to seek alternative suppliers and adjust logistics strategies to mitigate these disruptions. Despite the challenges, the growing demand for biologics and vaccines continues to drive the market, with manufacturers prioritizing resilient, flexible bioprocess solutions to ensure production continuity.

Key Takeaways 2D Bioprocess Containers are the Largest Segment

2D bioprocess containers dominate the bioprocess containers markets due to their cost-effectiveness and operational efficiency. Offering benefits such as easier storage, reduced contamination risk, and simplified handling, 2D containers meet the industry’s growing demand for scalable and flexible solutions. Additionally, their structure minimizes contamination risks and allows for easier handling, streamlining workflows and reducing labor-intensive procedures. As the biopharmaceutical industry grows, there is an increasing demand for scalable and flexible solutions to meet diverse production needs. 2D containers cater to these requirements by enabling single-use options that simplify transitions between processes, making them ideal for adaptable production setups.

Inquiry Before Buying:

Bioprocess Containers Market Segment Analysis — By Application

Cell culture is a major application of bioprocess containers (BPCs), playing a crucial role in the biomanufacturing industry. BPCs are extensively used for growing and maintaining mammalian, microbial, and insect cells, offering flexibility and scalability in production. They are designed with features like ports for sampling and reagent addition, and integrated sensors for monitoring environmental conditions. The increasing demand for biologics, including therapeutic proteins and vaccines, has driven the widespread adoption of BPCs in cell culture, making it a key focus in the development and manufacturing of biopharmaceutical products. According to Merck 2024, Merck invested $24.84 million to expand cell culture media production in Kansas, USA.

North America Dominates the Market

North America leads the global bioprocess container (BPC) market due to its advanced biopharmaceutical industry and substantial investments in research and development. The United States and Canada are at the forefront, driving significant growth with a strong focus on innovative single-use technologies and sophisticated manufacturing processes. The region’s robust infrastructure, presence of major biopharma companies, and commitment to cutting-edge advancements make North America a key player in the BPC market, particularly in applications such as cell culture, media preparation, and downstream processing. The United States dominates the pharmaceutical industry, home to some of the world’s largest companies like Pfizer, Johnson & Johnson, Merck & Co. and AbbVie. In July 2024, Despite the expected decrease in COVID-related revenue, Pfizer’s revenue rose 3% operationally to $28.2 billion. In December 2023, Pfizer finalized the $43 billion acquisition of Seagen (a biotech company), doubling its oncology pipeline. Such developments are a major catalyst for growth in the bioprocess container market, as it leads to a significant increase in the production of biopharmaceuticals, particularly in the oncology space.

Bioprocess Containers Market Drivers

Single Use Systems

The cost-effectiveness of single-use systems is a major driver of the bioprocess containers market. Single-use bioprocess containers significantly reduce operational costs compared to traditional stainless-steel systems by eliminating the need for time-consuming cleaning, sterilization, and maintenance. This leads to lower capital and operational expenses, making single-use systems an attractive option for biopharmaceutical manufacturers looking to streamline their processes and improve efficiency. As a result, the adoption of single-use bioprocess containers is increasing, driven by their economic advantages and the growing demand for flexible and cost-efficient manufacturing solutions. BioPlan’s 19th Annual Report and Survey of Biopharmaceutical Manufacturing indicates a substantial rise in the use of commercial-scale single-use (SUS) bioreactors, which grew from 32.5% in 2019 to 43% in 2022. This 32% increase is primarily due to the heightened demand for flexibility and rapid deployment in bioproduction during the COVID-19 pandemic.

Schedule A Call :

Rising Demand for Biopharmaceuticals

The rising demand for biopharmaceuticals is a key driver of the bioprocess containers market, particularly due to the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders among the aging population. As the global population of individuals aged 60 and above continues to grow, with significant increases in regions like North America, Europe, and parts of Asia, the need for advanced biologic treatments, including monoclonal antibodies, vaccines, and cell therapies, is intensifying. Bioprocess containers play a critical role in the production, storage, and transportation of these biopharmaceutical products, making them essential to meeting the growing demand. This surge in biopharmaceutical production is, in turn, driving the expansion of the bioprocess containers market. According to IDF projections, the number of adults living with diabetes will increase by 46% to 783 million by 2045, representing one in eight adults. The American Cancer Society (ACS) estimates that by 2050, the number of cancer cases is expected to rise to 35 million.

Bioprocess Containers Market Challenges

Regulatory Requirements

Regulatory requirements in the bioprocess container market pose a significant challenge due to the need to comply with stringent standards across various regions and applications. Manufacturers must navigate complex regulations, such as those from the FDA, ISO, and USP, which require rigorous validation and documentation. Staying up-to-date with evolving guidelines and ensuring that containers meet these standards is crucial for maintaining product safety and efficacy, but it adds complexity and cost to the manufacturing process. According to Cytiva, single-use bioprocess technologies are advanced but lack specific regulations, creating uncertainty about their suitability for therapeutic production and leaving bio manufacturers concerned about their appropriateness.

Buy Now :

Bioprocess Containers Market Key Players

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Bioprocess Containers Market. The top 10 players in the Bioprocess Containers Market are

Lonza Group AG

Corning Incorporated

Entegris, Inc.

Parker Hannifin Corporation

Meissner Filtration Products, Inc.

Merck KGaA

Avantor Inc.

Sartorius AG

Thermo Fisher Scientific Inc.

Cytiva,

For more Lifesciences and Healthcare Market reports, please click here